PlainRecalls
FDA Drug Low Class III Terminated

Buspirone Hydrochloride Tabs USP 10 mg, packaged in a) 15-count blister card (NDC 0615-7718-05) b) 30-count blister card (NDC 0615-7718-39), Rx only, Mfd By Pliva HRVATSKA for Teva USA, PKG by Vangard Glasgow, KY 42141.

Reported: November 29, 2023 Initiated: October 27, 2023 #D-0113-2024

Product Description

Buspirone Hydrochloride Tabs USP 10 mg, packaged in a) 15-count blister card (NDC 0615-7718-05) b) 30-count blister card (NDC 0615-7718-39), Rx only, Mfd By Pliva HRVATSKA for Teva USA, PKG by Vangard Glasgow, KY 42141.

Reason for Recall

Presence of Foreign Tablets: Potential of stray tablet(s) of Amlodipine Besylate 10 mg Tablet within the recalled lots

Details

Units Affected
1,344 cards
Distribution
Nationwide USA
Location
Glasgow, KY

Frequently Asked Questions

What product was recalled?
Buspirone Hydrochloride Tabs USP 10 mg, packaged in a) 15-count blister card (NDC 0615-7718-05) b) 30-count blister card (NDC 0615-7718-39), Rx only, Mfd By Pliva HRVATSKA for Teva USA, PKG by Vangard Glasgow, KY 42141.. Recalled by NCS Healthcare of Kentucky Inc. Units affected: 1,344 cards.
Why was this product recalled?
Presence of Foreign Tablets: Potential of stray tablet(s) of Amlodipine Besylate 10 mg Tablet within the recalled lots
Which agency issued this recall?
This recall was issued by the FDA Drug on November 29, 2023. Severity: Low. Recall number: D-0113-2024.